GENERIUM is a full-cycle innovative high-end pharmaceutical company. We are the leader in Russian orphan pharmaceutical market.
GENERIUM possesses its own R&D park, which is capable to handle the full cycle of development of any biological drug, from molecule design to commercial production. We are collaborating in science with leading biotechnological companies and institutes from all over the world.
GENERIUMs manufacturing facilities are equipped with high-end equipment. The work is organized under GMP standards and our plants are ready to produce any kind of biological drugs or ATMPs.
Our mission – our ideas to save life and health.
Company Details
- Employees
- 177
- Founded
- -
- Address
- 10 Testovskaya Street, Moscow,123112,russian Federation
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ibcgenerium.ru
- HQ
- Moscow
Generium Questions
Generium's website is ibcgenerium.ru
Generium's LinkedIn profile is https://ru.linkedin.com/company/ibc-generium
Generium has
177 employees.
View email and phone details for 177
employees at Generium.
Generium's industry is
Biotechnology Research
Generium's top competitors are
Pharmasyntez Group Of Companies,
Petrovax Pharm,
Binnopharm Group,
Biocad,
Rus Biopharm,
Solopharm,
Nanolek,
R-Pharm,
Geropharm,
Valenta Pharmaceuticals.
Generium's categories are Biotechnology Research
Generium's founding year is 2009
